REYKJAVIK, Iceland, 11. September. 2019. deCODE genetics in Iceland has entered into an agreement with a consortium of government, charity, researchers and world leading biopharmaceutical and healthcare companies to undertake whole genome sequencing of UK Biobank...
Kári Stefánsson, the founder and CEO of deCODE Genetics, now a subsidiary of Amgen, has been elected to the National Academy of Science (NAS). Election to the academy is one of the highest honors in the field of science and a recognition reserved for individuals whose...
Kári Stefánsson CEO of deCODE genetics seeks to unite Nordic researchers in genetic research to support more precise and personalised medical treatment . The Nordic Society of Human Genetics and Precision Medicine (NSHG-PM) has chosen its inaugural leadership....
A whole genome sequence-based portrait of how the two basic mechanisms generating human diversity work Elucidates how women and men contribute differently to diversity; how the genome promotes and regulates diversity; and the link between the generation of diversity...
Scientists at deCODE genetics have found a variant that protects against nasal polyps and chronic rhinosinusitis. The study was published on the 14th of January in the online edition of Nature genetics. Nasal polyps are non-malignant, typically bilateral growths on...
